Astellas and XenoPort launch restless legs syndrome tablets in Japan – Equities.com

by admin on September 4, 2012

Astellas and XenoPort launch restless legs syndrome tablets in Japan
Equities.com
Regnite was approved in Japan for the treatment of moderate-to-severe primary restless legs syndrome. Discovered by XenoPort, Regnite is dosed once-daily and delivers a new chemical entity that utilizes naturally-occurring, high-capacity, nutrient

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: